Annual EBITDA
-$7.29 M
+$53.50 K+0.73%
31 March 2023
Summary:
Nemaura Medical annual earnings before interest, taxes, depreciation & amortization is currently -$7.29 million, with the most recent change of +$53.50 thousand (+0.73%) on 31 March 2023. During the last 3 years, it has fallen by -$2.80 million (-62.34%). NMRD annual EBITDA is now -1154.02% below its all-time high of -$581.10 thousand, reached on 31 March 2014.NMRD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$155.40 K
+$92.10 K+37.21%
31 December 2023
Summary:
Nemaura Medical quarterly earnings before interest, taxes, depreciation & amortization is currently -$155.40 thousand, with the most recent change of +$92.10 thousand (+37.21%) on 31 December 2023. Over the past year, it has increased by +$92.10 thousand (+37.21%). NMRD quarterly EBITDA is now -612.84% below its all-time high of -$21.80 thousand, reached on 30 September 2013.NMRD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$4.50 M
+$382.00 K+7.83%
31 December 2023
Summary:
Nemaura Medical TTM earnings before interest, taxes, depreciation & amortization is currently -$4.50 million, with the most recent change of +$382.00 thousand (+7.83%) on 31 December 2023. Over the past year, it has increased by +$382.00 thousand (+7.83%). NMRD TTM EBITDA is now -7262.03% below its all-time high of -$61.10 thousand, reached on 30 June 2013.NMRD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMRD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +37.2% | +7.8% |
| 3 y3 years | -62.3% | +90.7% | +20.3% |
| 5 y5 years | -64.0% | +85.9% | +7.8% |
NMRD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -62.3% | +0.7% | at high | +93.4% | at high | +47.6% |
| 5 y | 5 years | -64.0% | +0.7% | at high | +93.4% | -2.9% | +47.6% |
| alltime | all time | -1154.0% | +0.7% | -612.8% | +93.4% | -7262.0% | +47.6% |
Nemaura Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | -$155.40 K(-37.2%) | -$4.50 M(-7.8%) |
| Sept 2023 | - | -$247.50 K(-86.6%) | -$4.88 M(-28.2%) |
| June 2023 | - | -$1.85 M(-17.8%) | -$6.80 M(-6.7%) |
| Mar 2023 | -$7.29 M(-0.7%) | -$2.25 M(+318.2%) | -$7.29 M(-1.4%) |
| Dec 2022 | - | -$537.40 K(-75.2%) | -$7.39 M(-13.9%) |
| Sept 2022 | - | -$2.16 M(-7.4%) | -$8.59 M(+6.1%) |
| June 2022 | - | -$2.34 M(-0.6%) | -$8.09 M(+10.3%) |
| Mar 2022 | -$7.34 M(+63.5%) | -$2.35 M(+35.6%) | -$7.34 M(+15.8%) |
| Dec 2021 | - | -$1.73 M(+3.9%) | -$6.34 M(+12.3%) |
| Sept 2021 | - | -$1.67 M(+5.3%) | -$5.64 M(+8.9%) |
| June 2021 | - | -$1.58 M(+17.4%) | -$5.18 M(+15.5%) |
| Mar 2021 | -$4.49 M(-5.0%) | -$1.35 M(+29.7%) | -$4.49 M(+0.2%) |
| Dec 2020 | - | -$1.04 M(-13.8%) | -$4.48 M(+0.0%) |
| Sept 2020 | - | -$1.21 M(+35.5%) | -$4.48 M(+2.5%) |
| June 2020 | - | -$890.90 K(-33.5%) | -$4.37 M(-7.5%) |
| Mar 2020 | -$4.72 M(+6.3%) | -$1.34 M(+28.8%) | -$4.72 M(-5.5%) |
| Dec 2019 | - | -$1.04 M(-5.4%) | -$5.00 M(+2.4%) |
| Sept 2019 | - | -$1.10 M(-11.6%) | -$4.88 M(-0.9%) |
| June 2019 | - | -$1.24 M(-22.9%) | -$4.92 M(+10.8%) |
| Mar 2019 | -$4.44 M | -$1.61 M(+75.2%) | -$4.44 M(+31.0%) |
| Dec 2018 | - | -$920.70 K(-19.6%) | -$3.39 M(+15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$1.14 M(+49.6%) | -$2.94 M(+31.7%) |
| June 2018 | - | -$765.20 K(+36.4%) | -$2.23 M(+18.8%) |
| Mar 2018 | -$1.88 M(+22.8%) | -$561.00 K(+19.6%) | -$1.88 M(+12.3%) |
| Dec 2017 | - | -$468.90 K(+7.2%) | -$1.67 M(+6.2%) |
| Sept 2017 | - | -$437.60 K(+6.1%) | -$1.58 M(+8.3%) |
| June 2017 | - | -$412.30 K(+16.3%) | -$1.45 M(-5.0%) |
| Mar 2017 | -$1.53 M(+0.6%) | -$354.40 K(-4.4%) | -$1.53 M(-3.7%) |
| Dec 2016 | - | -$370.80 K(+17.2%) | -$1.59 M(+3.0%) |
| Sept 2016 | - | -$316.40 K(-35.3%) | -$1.54 M(-4.3%) |
| June 2016 | - | -$489.30 K(+18.5%) | -$1.61 M(+6.0%) |
| Mar 2016 | -$1.52 M(+16.0%) | -$412.80 K(+26.9%) | -$1.52 M(-7.4%) |
| Dec 2015 | - | -$325.20 K(-15.6%) | -$1.64 M(+11.5%) |
| Sept 2015 | - | -$385.50 K(-3.3%) | -$1.47 M(+2.1%) |
| June 2015 | - | -$398.70 K(-25.3%) | -$1.44 M(+10.0%) |
| Mar 2015 | -$1.31 M(+125.8%) | -$533.90 K(+244.2%) | -$1.31 M(+39.9%) |
| Dec 2014 | - | -$155.10 K(-56.4%) | -$937.70 K(-16.4%) |
| Sept 2014 | - | -$355.50 K(+32.7%) | -$1.12 M(+42.3%) |
| June 2014 | - | -$267.80 K(+68.1%) | -$788.00 K(+35.6%) |
| Mar 2014 | -$581.10 K | -$159.30 K(-53.0%) | -$581.30 K(+37.7%) |
| Dec 2013 | - | -$339.10 K(+1455.5%) | -$422.00 K(+409.0%) |
| Sept 2013 | - | -$21.80 K(-64.3%) | -$82.90 K(+35.7%) |
| June 2013 | - | -$61.10 K | -$61.10 K |
FAQ
- What is Nemaura Medical annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Nemaura Medical?
- What is Nemaura Medical quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Nemaura Medical?
- What is Nemaura Medical quarterly EBITDA year-on-year change?
- What is Nemaura Medical TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Nemaura Medical?
- What is Nemaura Medical TTM EBITDA year-on-year change?
What is Nemaura Medical annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NMRD is -$7.29 M
What is the all time high annual EBITDA for Nemaura Medical?
Nemaura Medical all-time high annual earnings before interest, taxes, depreciation & amortization is -$581.10 K
What is Nemaura Medical quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NMRD is -$155.40 K
What is the all time high quarterly EBITDA for Nemaura Medical?
Nemaura Medical all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$21.80 K
What is Nemaura Medical quarterly EBITDA year-on-year change?
Over the past year, NMRD quarterly earnings before interest, taxes, depreciation & amortization has changed by +$92.10 K (+37.21%)
What is Nemaura Medical TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NMRD is -$4.50 M
What is the all time high TTM EBITDA for Nemaura Medical?
Nemaura Medical all-time high TTM earnings before interest, taxes, depreciation & amortization is -$61.10 K
What is Nemaura Medical TTM EBITDA year-on-year change?
Over the past year, NMRD TTM earnings before interest, taxes, depreciation & amortization has changed by +$382.00 K (+7.83%)